The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More
Login
Free Trial

Media Database S seekingalpha.com Stephen Ayers

Stephen Ayers
meremrtl

followers

RN / MBA | Seeking Alpha analyst | Deep biotech dives at "Molecule → Market"

Publications:
seekingalpha.com
Topics
bio, biotech
Recent articles
Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy' (NASDAQ:COGT)
Apr 02, 2026
seekingalpha.com
Insmed: The Pipeline Is Catching Up To The Valuation (NASDAQ:INSM)
Apr 01, 2026
seekingalpha.com
Liquidia: Yutrepia Has Impressed, But I Remain Cautious (Rating Upgrade) (NASDAQ:LQDA)
Mar 26, 2026
seekingalpha.com
Why Corcept's Ovarian Cancer 'Hail Mary' Might Actually Land (NASDAQ:CORT)
Mar 21, 2026
seekingalpha.com
Tenax Therapeutics: A Binary Bet With Heavy Downside Likely (NASDAQ:TENX)
Mar 18, 2026
seekingalpha.com
CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade) (CTMX)
Mar 16, 2026
seekingalpha.com
Trevi Therapeutics: Navigating The 'Catch-22' Of Opioid-Based Cough Control (NASDAQ:TRVI)
Mar 11, 2026
seekingalpha.com
ImmunityBio: Disconnect Between Clinical Progress And Stock Performance (NASDAQ:IBRX)
Feb 26, 2026
seekingalpha.com
Block: The Bitcoin Facade Hiding A Double-Digit Core Growth Story (NYSE:XYZ)
Feb 20, 2026
seekingalpha.com
Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case (NASDAQ:MRNA)
Feb 12, 2026
seekingalpha.com

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account